Report cover image

Global Doxorubicin Hydrochloride Supply, Demand and Key Producers, 2026-2032

Publisher GlobalInfoResearch
Published Jan 05, 2026
Length 106 Pages
SKU # GFSH20789061

Description

The global Doxorubicin Hydrochloride market size is expected to reach $ 99 million by 2032, rising at a market growth of 6.5% CAGR during the forecast period (2026-2032).

Doxorubicin hydrochloride is a type of chemotherapy drug called an anthracycline. It blocks an enzyme called topoisomerase II, which cuts and repairs tangled strands of DNA. This stops or slows the growth of cancer cells and other rapidly dividing cells.1

The global core manufacturers of Doxorubicin Hydrochloride include Pfizer, Teva and Viatris. The top three companies have a market share of about 50%. Asia Pacific is the world's largest market for Doxorubicin Hydrochloride with a market share of about 39%, followed by North America and Europe with a market share of 30% and 27%, respectively. In terms of product type, 10mg is the largest segment with approximately 32% market share. In terms of application, Lung Cancer is the largest downstream segment, accounting for about 24% of the market.

This report studies the global Doxorubicin Hydrochloride production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Doxorubicin Hydrochloride and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Doxorubicin Hydrochloride that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Doxorubicin Hydrochloride total production and demand, 2021-2032, (K Units)

Global Doxorubicin Hydrochloride total production value, 2021-2032, (USD Million)

Global Doxorubicin Hydrochloride production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)

Global Doxorubicin Hydrochloride consumption by region & country, CAGR, 2021-2032 & (K Units)

U.S. VS China: Doxorubicin Hydrochloride domestic production, consumption, key domestic manufacturers and share

Global Doxorubicin Hydrochloride production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)

Global Doxorubicin Hydrochloride production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)

Global Doxorubicin Hydrochloride production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)

This report profiles key players in the global Doxorubicin Hydrochloride market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva, Viatris, Medac GmbH, Fresenius Kabi, Sun Pharmaceutical, Shanxi PUDE Pharmaceutical, Zhejiang Hisun (HanHui Pharmaceuticals), Shenzhen Main Luck Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Doxorubicin Hydrochloride market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Doxorubicin Hydrochloride Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Doxorubicin Hydrochloride Market, Segmentation by Type:
10mg
20mg
50mg
200mg
Others

Global Doxorubicin Hydrochloride Market, Segmentation by Application:
Breast Cancer
Acute Leukemia
Lung Cancer
Malignant Lymphoma
Others

Companies Profiled:
Pfizer
Teva
Viatris
Medac GmbH
Fresenius Kabi
Sun Pharmaceutical
Shanxi PUDE Pharmaceutical
Zhejiang Hisun (HanHui Pharmaceuticals)
Shenzhen Main Luck Pharmaceuticals

Key Questions Answered:

1. How big is the global Doxorubicin Hydrochloride market?

2. What is the demand of the global Doxorubicin Hydrochloride market?

3. What is the year over year growth of the global Doxorubicin Hydrochloride market?

4. What is the production and production value of the global Doxorubicin Hydrochloride market?

5. Who are the key producers in the global Doxorubicin Hydrochloride market?

6. What are the growth factors driving the market demand?

Table of Contents

106 Pages
1 Supply Summary
2 Demand Summary
3 World Manufacturers Competitive Analysis
4 United States VS China VS Rest of the World
5 Market Analysis by Type
6 Market Analysis by Application
7 Company Profiles
8 Industry Chain Analysis
9 Research Findings and Conclusion
10 Appendix

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us